QA: Nanoviricides INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2012_Nanoviricides_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 9,556,317
1 IntangibleAssetsNetIncludingGoodwill 399,383
2 PropertyPlantAndEquipmentNet 802,367
3 remainder_Assets 0
4 LiabilitiesCurrent 587,176
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,273,609
9 ResearchAndDevelopmentExpense 4,155,846
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -47,710
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,758,067
1 Liabilities 587,176
2 Expenses 6,429,455
3 Revenues 0
4 StockholdersEquity 10,170,891
5 NetIncome -6,477,165
6 ComprehensiveNetIncome -6,477,165
7 BaseVar 8,911,204
8 EconomicCapitalRatiobeforeLimitedLiability 2.77
9 EconomicCapitalRatio 3.53

Edgar->Model Mapping

Feature Distribution